Intramuscular Versus Intravenous Prophylactic Oxytocin for Hemorrhage After Vaginal Delivery

• Status: Unknown status
• Trial end date: 2015-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour following vaginal delivery: A randomised controlled trial

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hediye Dagdeviren
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

1. Research volunteers, the undersigned, pregnant women

2. Only with vaginal delivery (episiotomy and perineal tears can)

3. > 34 weeks or more will be

4. Cephalic presentation will be

5. At low risk of postpartum hemorrhage

Exclusion Criteria:

1. <18 years

2. Multiple pregnancies

3. The presence of uterine myoma

4. Having postpartum hemorrhage in previous pregnancies

5. Placenta previa, polyhydramnios

6. More than four parity

7. Fetal macrosomia

8. Hb <9mg/dl

9. preeclampsia

10. Uterine anomalies

11. Receiving anticoagulant therapy, suspected coagulopathy

12. > 42 weeks of pregnancy

13. Oxytocin allergy -